[1]Patent:WO2012/85167,2012,A1.Locationinpatent:Page/Pagecolumn60
[2]Patent:WO2012/85167,2012,A1.Locationinpatent:Page/Pagecolumn51
Title: Antinociceptive synergism of MD-354 and clonidine. Part II. The alpha-adrenoceptor component.
Journal: Basic & clinical pharmacology & toxicology 20100801
Title: MD-354 selectively antagonizes the antinociceptive effects of (-)nicotine in the mouse tail-flick assay.
Journal: Psychopharmacology 20100701
Title: A comprehensive study on the 5-hydroxytryptamine(3A) receptor binding of agonists serotonin and m-chlorophenylbiguanidine.
Journal: Bioorganic & medicinal chemistry 20090815
Title: MD-354: what is it good for?
Journal: CNS drug reviews 20070101
Title: The 5-HT3 receptor partial agonist MD-354 (meta-chlorophenylguanidine) enhances the discriminative stimulus actions of (+)amphetamine in rats.
Journal: Pharmacology, biochemistry, and behavior 20070101
Title: Antinociception: mechanistic studies on the action of MD-354 and clonidine. Part 1. The 5-HT3 component.
Journal: European journal of pharmacology 20051228
Title: MD-354 potentiates the antinociceptive effect of clonidine in the mouse tail-flick but not hot-plate assay.
Journal: European journal of pharmacology 20040714
Title: Conformationally-restricted analogues and partition coefficients of the 5-HT3 serotonin receptor ligands meta-chlorophenylbiguanide (mCPBG) and meta-chlorophenylguanidine (mCPG).
Journal: Bioorganic & medicinal chemistry letters 20030324
Title: Electrostatic potential surfaces of 5-HT(3)R agonists suggest accessory cation-pi site adjacent to agonist binding domain.
Journal: Bioorganic & medicinal chemistry letters 20021007
Title: The binding of arylguanidines at 5-HT(3) serotonin receptors: a structure-affinity investigation.
Journal: Bioorganic & medicinal chemistry letters 20010618
